In 2013, a groundbreaking federal jury verdict declared that a connection existed between ovarian cancer and the daily use of feminine powder products containing talc. While that jury chose not to levy damages against consumer health products giant Johnson & Johnson, its verdict marked the first time the company would be told by a jury that it failed to warn consumers about deleterious health effects.
The verdict also foreshadowed an expanding legal fight that saw its first substantial monetary verdicts in 2016.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
